IrishAngels

IrishAngels is an early-stage venture firm based in Chicago, Illinois, founded in 2012. The firm focuses on investing in high-potential startups across the United States, specifically in sectors such as software, consumer products, and medical devices. The IrishAngels network comprises 225 investors, including prominent venture capital and private equity professionals, along with experienced entrepreneurs. This diverse group collaborates to identify and support innovative companies in their early stages, facilitating growth and development within the startup ecosystem.

Jordan Curnes

Director of Board

Past deals in Indiana

TayCo Brace

Seed Round in 2021
TayCo Brace is a medical device company that manufactures a custom-fit external ankle brace. The TayCo Brace offers immediate functional recovery for driving, work, and sports. It is custom fit for enhanced stability, performance, and comfort.

Malomo

Seed Round in 2020
Malomo, Inc. develops an application for shipment marketing for e-commerce companies. Its platform allows e-commerce brands to generate revenue and loyalty by turning shipment tracking into a brand marketing channel; and enables companies to message customers with tracking information and include branded communication. The company’s platform also connects with customers’ e-commerce sites and into the software of its customers’ shipping providers. Malomo, Inc. was founded in 2018 and is based in Indianapolis, Indiana.

Pattern89

Seed Round in 2018
Pattern89 Inc. develops a predictive marketing artificial intelligence platform for marketers and ad agencies to maximize digital and social media ad performance. Its tool identifies trends, automates campaign selection, drills analysis of data elements, optimizes campaign spending, and offers real time campaign performance and reporting. Pattern89 Inc. was formerly known as Quantifi, Inc. and changed its name to Pattern89 Inc. in April 2018. The company was incorporated in 2016 and is headquartered in Indianapolis, Indiana.

Emu Technology

Convertible Note in 2018
Emu Technology is focused on developing innovative hardware and software solutions that enhance memory utilization and eliminate data bottlenecks in microprocessors. Founded in 2004 and headquartered in South Bend, Indiana, the company has established strategic partnerships with notable firms such as Graham Allen Partners, Aunalytics, Data Realty, and Qumulus Solutions. A key offering from Emu Technology is the next-generation Lucata computer architecture, which significantly accelerates graph analytics, allowing organizations to conduct high-performance, multi-hop analytics on vast databases with up to one trillion vertices. This architecture leverages patented migrating thread technology to scale unified memory and facilitates deeper data analysis using existing graph database software or custom solutions. Emu Technology's solutions are applicable across various sectors, including financial services, cybersecurity, healthcare, telecommunications, and government, thereby enabling organizations to harness the power of advanced analytics and machine learning.

myCOI

Series A in 2018
myCOI provides a SaaS-based certificate of insurance (COI) management solutions in the United States. The company’s solutions specialize in pharmaceutical, construction, and municipal certificate management. Its Web-based solution enables businesses and municipalities to automate COI collection, compliance validation, and tracking. The company serves construction and development, property/tenant management, franchisee management, trucking, retail, pharmaceutical, hospital, and manufacturing industries, as well as public utilities, universities, financial institutes, and city and state governments. My COI, LLC was incorporated in 2009 and is based in Marion, Indiana.

AgenDx Biosciences

Seed Round in 2018
AgenDx is an early stage molecular diagnostics company developing a revolutionary cost-effective molecular diagnostics platform. Their novel technology allows simple molecular diagnostic lab-quality testing. With a quick sample-to-answer in minutes, their platform is positioned to transform where and how disease is detected and treated. Their platform accommodates a wide range of nucleic-acid based tests for infectious disease, cancer, and other chronic conditions including cardiovascular disease and arthritis. Their initial focus is to prove the AgenDx technology by developing tests for aiding physician’s treatment decisions for pancreatic cancer. Their platform is designed for operation by untrained users in clinical settings near the patient. The sample is collected and inserted into a disposable cartridge. A control system automates and runs the test. Clear results will be displayed and transmitted. Their proprietary system will accommodate any biological sample, including blood, saliva, and tissue.

Emu Technology

Series A in 2017
Emu Technology is focused on developing innovative hardware and software solutions that enhance memory utilization and eliminate data bottlenecks in microprocessors. Founded in 2004 and headquartered in South Bend, Indiana, the company has established strategic partnerships with notable firms such as Graham Allen Partners, Aunalytics, Data Realty, and Qumulus Solutions. A key offering from Emu Technology is the next-generation Lucata computer architecture, which significantly accelerates graph analytics, allowing organizations to conduct high-performance, multi-hop analytics on vast databases with up to one trillion vertices. This architecture leverages patented migrating thread technology to scale unified memory and facilitates deeper data analysis using existing graph database software or custom solutions. Emu Technology's solutions are applicable across various sectors, including financial services, cybersecurity, healthcare, telecommunications, and government, thereby enabling organizations to harness the power of advanced analytics and machine learning.

Emu Technology

Convertible Note in 2017
Emu Technology is focused on developing innovative hardware and software solutions that enhance memory utilization and eliminate data bottlenecks in microprocessors. Founded in 2004 and headquartered in South Bend, Indiana, the company has established strategic partnerships with notable firms such as Graham Allen Partners, Aunalytics, Data Realty, and Qumulus Solutions. A key offering from Emu Technology is the next-generation Lucata computer architecture, which significantly accelerates graph analytics, allowing organizations to conduct high-performance, multi-hop analytics on vast databases with up to one trillion vertices. This architecture leverages patented migrating thread technology to scale unified memory and facilitates deeper data analysis using existing graph database software or custom solutions. Emu Technology's solutions are applicable across various sectors, including financial services, cybersecurity, healthcare, telecommunications, and government, thereby enabling organizations to harness the power of advanced analytics and machine learning.

Emu Technology

Series A in 2016
Emu Technology is focused on developing innovative hardware and software solutions that enhance memory utilization and eliminate data bottlenecks in microprocessors. Founded in 2004 and headquartered in South Bend, Indiana, the company has established strategic partnerships with notable firms such as Graham Allen Partners, Aunalytics, Data Realty, and Qumulus Solutions. A key offering from Emu Technology is the next-generation Lucata computer architecture, which significantly accelerates graph analytics, allowing organizations to conduct high-performance, multi-hop analytics on vast databases with up to one trillion vertices. This architecture leverages patented migrating thread technology to scale unified memory and facilitates deeper data analysis using existing graph database software or custom solutions. Emu Technology's solutions are applicable across various sectors, including financial services, cybersecurity, healthcare, telecommunications, and government, thereby enabling organizations to harness the power of advanced analytics and machine learning.

Vennli

Seed Round in 2016
Vennli, Inc. is a choice visualization analytics platform that assists businesses in understanding customer decision-making processes. By providing real-time insights into customer preferences, Vennli enables companies to make informed decisions regarding business growth and competitive positioning. The platform focuses on enhancing marketing relevance by guiding marketers in developing effective messaging and content strategies that resonate with customers. Founded in 2013 and based in South Bend, Indiana, Vennli aims to optimize marketing efforts by ensuring that the right message reaches the right audience at the right time, ultimately improving conversion rates and reducing wasteful spending on ineffective content and promotions.

AgenDx Biosciences

Seed Round in 2016
AgenDx is an early stage molecular diagnostics company developing a revolutionary cost-effective molecular diagnostics platform. Their novel technology allows simple molecular diagnostic lab-quality testing. With a quick sample-to-answer in minutes, their platform is positioned to transform where and how disease is detected and treated. Their platform accommodates a wide range of nucleic-acid based tests for infectious disease, cancer, and other chronic conditions including cardiovascular disease and arthritis. Their initial focus is to prove the AgenDx technology by developing tests for aiding physician’s treatment decisions for pancreatic cancer. Their platform is designed for operation by untrained users in clinical settings near the patient. The sample is collected and inserted into a disposable cartridge. A control system automates and runs the test. Clear results will be displayed and transmitted. Their proprietary system will accommodate any biological sample, including blood, saliva, and tissue.

Vennli

Convertible Note in 2014
Vennli, Inc. is a choice visualization analytics platform that assists businesses in understanding customer decision-making processes. By providing real-time insights into customer preferences, Vennli enables companies to make informed decisions regarding business growth and competitive positioning. The platform focuses on enhancing marketing relevance by guiding marketers in developing effective messaging and content strategies that resonate with customers. Founded in 2013 and based in South Bend, Indiana, Vennli aims to optimize marketing efforts by ensuring that the right message reaches the right audience at the right time, ultimately improving conversion rates and reducing wasteful spending on ineffective content and promotions.